In Alzheimer's, brain cells die too soon. In cancer, dangerous cells don't die soon enough. That's because both diseases alter the way cells decide when to end their lives, a process called programmed ...
In its effort to correlate genomic structure with gene function, the 4D Nucleome Consortium (4DN), led by Job Dekker, Ph.D., ...
Randal Halfmann at the Stowers Institute for Medical Research in Kansas City is hoping to treat diseases including cancer and Alzheimer's by influencing how cells make life-or-death decisions. In ...
Researchers are exploring the behavior of "death fold" proteins in the hopes of understanding why some cells die too soon and why others don't die soon enough. In Alzheimer's, brain cells die too soon ...